Want to see JP:7779 full AI Analyst Report?
7779 Stock Chart & Stats
¥231.00
¥6.00(2.71%)
At close: 4:00 PM EDT
¥231.00
¥6.00(2.71%)
Day’s Range― - ―
52-Week Range¥164.00 - ¥420.00
Previous CloseN/A
Volume795.20K
Average Volume (3M)756.25K
Market Cap
¥42.23B
Enterprise Value¥37.03B
Total Cash (Recent Filing)¥13.12B
Total Debt (Recent Filing)¥540.00M
Price to Earnings (P/E)153.8
Beta1.01
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding137,445,820
10 Day Avg. Volume1,002,280
30 Day Avg. Volume756,246
Financial Highlights & Ratios
PEG Ratio-2.89
Price to Book (P/B)1.40
Price to Sales (P/S)14.44
P/FCF Ratio305.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥380.00Price Target Upside64.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)4.1
Revenue Forecast (FY)¥4.87B
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Gross MarginStrong TTM revenue growth alongside a solid gross margin indicates meaningful demand for the company’s products and favorable product economics. If sustained, this combination can support greater operating leverage, strengthen reinvestment capacity, and improve the scalability of HAL-related business activities.
Low Financial LeverageVery low leverage gives CYBERDYNE substantial financial flexibility while it develops and commercializes its robotics portfolio. A conservatively funded balance sheet reduces reliance on borrowing and leaves more capacity to absorb operating volatility or support continued investment in healthcare and rehabilitation technologies.
Specialized Medical Robotics PlatformCYBERDYNE has a differentiated business focus built around wearable robotics, cybernics, and rehabilitation applications rather than a broad commodity product range. This specialized platform can support durable positioning if HAL and related systems continue addressing medical, nursing-care, and human-assistance needs.
Bears Say
Weak Operating ProfitabilityNegative EBIT and EBITDA margins show that the core operating business is not yet covering its costs, limiting the durability of reported earnings. Continued operating losses could constrain self-funded expansion and make future profitability dependent on achieving substantial scale or improving cost efficiency.
Negative Cash GenerationCurrent operating and free cash flow are negative, indicating that revenue and reported income are not translating into cash generation. Persistent cash burn can increase reliance on the company’s balance sheet to fund operations, product development, and commercialization, reducing financial flexibility over time.
Low Returns On CapitalAlthough TTM return on equity has turned modestly positive, the approximately 0.7% level remains weak and follows negative returns in earlier periods. This indicates that the substantial equity base is not yet producing strong shareholder returns, underscoring the need for more durable operating profitability.
CYBERDYNE News
7779 FAQ
What was CYBERDYNE Inc.’s price range in the past 12 months?
CYBERDYNE Inc. lowest stock price was ¥164.00 and its highest was ¥420.00 in the past 12 months.
What is CYBERDYNE Inc.’s market cap?
CYBERDYNE Inc.’s market cap is ¥42.23B.
When is CYBERDYNE Inc.’s upcoming earnings report date?
CYBERDYNE Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 13 days.
How were CYBERDYNE Inc.’s earnings last quarter?
CYBERDYNE Inc. released its earnings results on Aug 13, 2026. The company reported ¥1.77 earnings per share for the quarter.
Is CYBERDYNE Inc. overvalued?
According to Wall Street analysts CYBERDYNE Inc.’s price is currently Undervalued.
Does CYBERDYNE Inc. pay dividends?
CYBERDYNE Inc. does not currently pay dividends.
What is CYBERDYNE Inc.’s EPS estimate?
CYBERDYNE Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYBERDYNE Inc. have?
CYBERDYNE Inc. has 137,445,820 shares outstanding.
What happened to CYBERDYNE Inc.’s price movement after its last earnings report?
CYBERDYNE Inc. reported an EPS of ¥1.77 in its last earnings report. Following the earnings report the stock price went up 1.255%.
Which hedge fund is a major shareholder of CYBERDYNE Inc.?
Currently, no hedge funds are holding shares in JP:7779
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYBERDYNE Inc.
Headquartered in Tsukuba, Japan, and founded in 2004, CYBERDYNE Inc. is dedicated to the ongoing research, development, production, sales, leasing, and maintenance of sophisticated equipment and systems, primarily for the medical and defense sectors within Japan. Their innovative product line features the Hybrid Assistive Limb (HAL), available in medical variants for lower limbs and single joints, as well as non-medical versions designed for lower limbs, single joints, and lumbar support. The company also supplies HAL peripherals, robotic cleaners, and autonomous transport robots for factories, offices, and various other indoor environments. A notable technological offering is Acoustic X, a high-speed light pulse LED array that facilitates real-time photoacoustic imaging. Complementing their hardware, CYBERDYNE provides specialized treatments and programs such as Cybernics Treatment, which utilizes HAL to restore or enhance function for individuals suffering from conditions like spinal cord injuries, strokes, and neuromuscular disorders. They additionally offer HAL FIT and Neuro HALFIT to improve brain-nerve-musculoskeletal and general physical functions, respectively, and MTX Neuro HAL Plus to optimize brain-nerve performance in athletes. Furthermore, the company extends its expertise to critical areas including disaster rescue operations, heavy industrial labor assistance, and contributions to the entertainment industry.
7779 Stock 12 Month Forecast
Average Price Target
¥380.00
▲(64.50% Upside)
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―








